Search by Drug Name or NDC
NDC 59779-0374-87 migraine relief 250; 250; 65 mg/1; mg/1; mg/1 Details
migraine relief 250; 250; 65 mg/1; mg/1; mg/1
migraine relief is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by CVS Pharmacy. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
| NDC | 59779-0374 |
|---|---|
| Product ID | 59779-374_34071859-042b-4006-9112-0f79158d8976 |
| Associated GPIs | |
| GCN Sequence Number | 040186 |
| GCN Sequence Number Description | aspirin/acetaminophen/caffeine TABLET 250-250-65 ORAL |
| HIC3 | H3D |
| HIC3 Description | ANALGESIC/ANTIPYRETICS, SALICYLATES |
| GCN | 10414 |
| HICL Sequence Number | 001807 |
| HICL Sequence Number Description | ASPIRIN/ACETAMINOPHEN/CAFFEINE |
| Brand/Generic | Generic |
| Proprietary Name | migraine relief |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | acetaminophen, aspirin, caffeine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 250; 250; 65 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Labeler Name | CVS Pharmacy |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075794 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59779-0374-87 (59779037487)
| NDC Package Code | 59779-374-87 |
|---|---|
| Billing NDC | 59779037487 |
| Package | 300 TABLET, FILM COATED in 1 BOTTLE (59779-374-87) |
| Marketing Start Date | 2018-09-21 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |